Synovus Financial’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Synovus Financial’s Portfolio BIVV Stock Details BIVV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-13,293	Closed	-$715K	–	1231
2017 Q4	$715K	Sell	13,293 -14,043	-51%	-$768K	0.01%	354
2017 Q3	$1.56M	Buy	27,336 +2,379	+10%	+$139K	0.03%	219
2017 Q2	$1.51M	Buy	24,957 +1,096	+5%	+$62.4K	0.03%	228
2017 Q1	$1.3M	Buy	+23,861	New	+$1.18M	0.03%	230

Other funds holding BIVV

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

ACS

Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Synovus Financial's BIVV Position: Q1 2018 in Review

Synovus Financial sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 13,293 shares — an estimated $715K sold.

Synovus Financial first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $1.56M in Q3 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

Synovus Financial reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
Synovus Financial sold 13,293 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $715K.
Synovus Financial first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
Synovus Financial's Bioverativ Inc. Common Stock position peaked at $1.56M in Q3 2017.
2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Synovus Financial's 13F filing for Q1 2018, filed 7 May 2018.